We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
NOWDiagnostics has announced study results for its ADEXUSDx® COVID-19 antibody test yielded encouraging test performance—providing a strong use case for the innovative diagnostic device, which was filed for Emergency Use Authorization (EUA) from ...
NOWDiagnostics has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 antibody test for use in moderate/complex laboratory settings across 28 countries in the European Union (EU).